CERT trades 62.5% below Wall Street's consensus target of $9.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CERT achieves its forward estimates and maintains a stable P/E multiple of 14.4x. This scenario reflects the blended consensus of 16 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Certara, Inc. (CERT) has a Wall Street consensus price target of $9.00, based on estimates from 16 covering analysts. With the stock currently trading at $5.54, this represents a potential upside of +62.5%. The company has a market capitalization of $862M.
Analyst price targets range from a low of $8.00 to a high of $10.00, representing a 22% spread in expectations. The median target of $9.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CERT trades at a trailing P/E of -554.0x and forward P/E of 14.4x. Analysts expect EPS to grow +501.1% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MEDPMedpace Holdings, Inc. | $13.1B | $460.20 | $498.86 | +8.4% | Hold | 27.1x | 19 |
IQVIQVIA Holdings Inc. | $28.5B | $167.77 | $219.44 | +30.8% | Buy | 13.1x | 44 |
CRLCharles River Laboratories International, Inc. | $8.9B | $185.00 | $214.14 | +15.8% | Buy | 16.7x | 37 |
VEEVVeeva Systems Inc. | $24.9B | $153.30 | $235.38 | +53.5% | Buy | 16.9x | 43 |
SLPSimulations Plus, Inc. | $367M | $18.24 | $18.50 | +1.4% | Hold | 21.1x | 9 |
SDGRSchrödinger, Inc. | $1.2B | $15.76 | $18.00 | +14.2% | Buy | — | 12 |
RXRXRecursion Pharmaceuticals, Inc. | $1.4B | $3.23 | $5.50 | +70.3% | Hold | — | 10 |
EXLSExlService Holdings, Inc. | $4.1B | $25.93 | $40.25 | +55.2% | Buy | 11.6x | 19 |
PFEPfizer Inc. | $143.5B | $25.22 | $26.75 | +6.1% | Hold | 8.5x | 39 |
MRKMerck & Co., Inc. | $281.2B | $113.87 | $131.58 | +15.6% | Buy | 22.2x | 37 |
Quick answers to the most common questions about buying CERT stock.
The consensus Wall Street price target for CERT is $9, representing 62.5% upside from the current price of $5.54. With 16 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CERT has a consensus rating of "Buy" based on 16 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $9 implies 62.5% upside from current levels.
With a forward P/E of 14.4308x, CERT trades at a relatively low valuation. The consensus target of $9 implies 62.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $10 for CERT, while the most conservative target is $8. The consensus of $9 represents the median expectation. These targets typically reflect 12-month expectations.
CERT is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 8 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CERT stock forecast based on 16 Wall Street analysts shows a consensus price target of $9, with estimates ranging from $8 (bear case) to $10 (bull case). The median consensus rating is "Buy".
CERT trades at a forward P/E ratio of 14.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CERT, with a "Buy" consensus rating and $9 price target (62.5% upside). 8 of 16 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CERT analyst price targets range from $8 to $10, a 22% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $9 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.